Wolfgang Renner
Präsident bei Alpha Anomeric SAS
Profil
Wolfgang A.
Renner is the founder of Cytos Biotechnology AG, which was founded in 1995.
He held the title of Chief Executive Officer & Head-Media Relations in 2011.
Currently, he is the President & Director of Alpha Anomeric SAS and a Member of both the Swiss Federation of Commerce & Industry and the Swiss National Science Foundation.
Dr. Renner received a doctorate degree from the Swiss Federal Institute of Technology in 1995.
Aktive Positionen von Wolfgang Renner
| Unternehmen | Position | Beginn |
|---|---|---|
| Swiss Federation of Commerce & Industry | Corporate Officer/Principal | 13.05.2010 |
| Swiss National Science Foundation | Corporate Officer/Principal | 13.05.2010 |
Alpha Anomeric SAS
 Alpha Anomeric SAS Pharmaceuticals: MajorHealth Technology Alpha Anomeric SAS Develops genetic medicines for severe neuromuscular diseases. The company is headquartered in Paris, France. | Präsident | - |
Ehemalige bekannte Positionen von Wolfgang Renner
| Unternehmen | Position | Ende |
|---|---|---|
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Gründer | 01.08.2011 |
Ausbildung von Wolfgang Renner
| Swiss Federal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
| Swiss Federation of Commerce & Industry | |
| Swiss National Science Foundation | |
Alpha Anomeric SAS
Alpha Anomeric SAS Pharmaceuticals: MajorHealth Technology Alpha Anomeric SAS Develops genetic medicines for severe neuromuscular diseases. The company is headquartered in Paris, France. | Health Technology |
